205 related articles for article (PubMed ID: 9275027)
1. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.
Sauter ER; Ross E; Daly M; Klein-Szanto A; Engstrom PF; Sorling A; Malick J; Ehya H
Br J Cancer; 1997; 76(4):494-501. PubMed ID: 9275027
[TBL] [Abstract][Full Text] [Related]
2. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
3. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings.
Sauter ER; Wagner-Mann C; Ehya H; Klein-Szanto A
Cancer Detect Prev; 2007; 31(1):50-8. PubMed ID: 17317033
[TBL] [Abstract][Full Text] [Related]
4. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.
Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF
Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885
[TBL] [Abstract][Full Text] [Related]
5. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
[TBL] [Abstract][Full Text] [Related]
6. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
[TBL] [Abstract][Full Text] [Related]
7. Nipple aspirate fluid color is associated with breast cancer.
Sauter ER; Winn JN; Dale PS; Wagner-Mann C
Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
[TBL] [Abstract][Full Text] [Related]
8. Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy.
Sauter ER; Ehya H; Mammen A; Klein G
Br J Cancer; 2001 Dec; 85(12):1952-7. PubMed ID: 11747339
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen production in the female breast: association with progesterone.
Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787
[TBL] [Abstract][Full Text] [Related]
10. Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review.
Hornberger J; Chen SC; Li Q; Kakad P; Quay SC
Curr Med Res Opin; 2015 Feb; 31(2):253-62. PubMed ID: 25405383
[TBL] [Abstract][Full Text] [Related]
11. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
Sauter ER; Tichansky DS; Chervoneva I; Diamandis EP
Environ Health Perspect; 2002 Mar; 110(3):241-6. PubMed ID: 11882474
[TBL] [Abstract][Full Text] [Related]
12. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer.
Varnum SM; Covington CC; Woodbury RL; Petritis K; Kangas LJ; Abdullah MS; Pounds JG; Smith RD; Zangar RC
Breast Cancer Res Treat; 2003 Jul; 80(1):87-97. PubMed ID: 12889602
[TBL] [Abstract][Full Text] [Related]
13. High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer.
Hsiung R; Zhu W; Klein G; Qin W; Rosenberg A; Park P; Rosato E; Sauter E
Cancer J; 2002; 8(4):303-10. PubMed ID: 12184408
[TBL] [Abstract][Full Text] [Related]
14. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens.
Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ
Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851
[TBL] [Abstract][Full Text] [Related]
15. Nipple aspirate cytology for the study of breast cancer precursors.
King EB; Chew KL; Petrakis NL; Ernster VL
J Natl Cancer Inst; 1983 Dec; 71(6):1115-21. PubMed ID: 6581355
[TBL] [Abstract][Full Text] [Related]
16. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
[TBL] [Abstract][Full Text] [Related]
17. Lavage and nipple aspiration of breast ductal fluids: a source of biomarkers for environmental mutagenesis.
Klein PM; Lawrence JA
Environ Mol Mutagen; 2002; 39(2-3):127-33. PubMed ID: 11921180
[TBL] [Abstract][Full Text] [Related]
18. Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study.
Baltzell KA; Moghadassi M; Rice T; Sison JD; Wrensch M
BMC Cancer; 2008 Mar; 8():75. PubMed ID: 18366688
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Nipple Aspirate Fluid Cytology in Asymptomatic Patients: A Meta-analysis and Systematic Review of the Literature.
Jiwa N; Gandhewar R; Chauhan H; Ashrafian H; Kumar S; Wright C; Takats Z; Leff DR
Ann Surg Oncol; 2021 Jul; 28(7):3751-3760. PubMed ID: 33165721
[TBL] [Abstract][Full Text] [Related]
20. Association of abnormal nipple aspirate cytology and mammographic pattern and density.
Lee MM; Petrakis NL; Wrensch MR; King EB; Miike R; Sickles E
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):33-6. PubMed ID: 8118383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
